fig7
Figure 7. Expression of miR-186-5p in BC tissues of patients (n. 18) distributed into three groups with differential effect of complete scheme of PTX-based therapy evaluated after surgery using Residual Cancer Border Classification. Statistical significance was estimated by the Kruskal-Wallis test (**P < 0,005). Graphs were plotted and statistical analysis was performed using GraphPad Prism software. PTX: Paclitaxel.
